Business Standard

Monday, December 30, 2024 | 10:32 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

ICMR asks states to use rapid test only for surveillance, not diagnosis

On Tuesday, it had asked states to stop using the kits for two days after receiving complaints of poor detection and faulty results

icmr, testing, test, plasma therapy, research, blood, clinics, laboratory, labs
Premium

The medical research body has told the states that these test kits cannot replace the RT-PCR test which is considered the gold standard in diagnosing Covid-19 cases

Ruchika Chitravanshi New Delhi
The Indian Council of Medical Research (ICMR) has told states to use the Chinese rapid antibody test kits only as a tool for surveillance and not to diagnose coronavirus disease (Covid-19) cases.
 
The ICMR on Tuesday had asked states to stop using the kits for two days after receiving complaints of poor detection and faulty results. “Globally also, the utility of this test is evolving and it is currently being used for detecting the formation of antibodies in individuals. These test results are also dependent on field conditions,” a press statement said.
 
The medical research body has told states that
Topics : Coronavirus

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in